RXRXRecursion Pharmaceuticals, Inc.

$3.48

What is the market doing?

What the tape says about RXRX

Recursion Pharmaceuticals, Inc. is −36% over the past year while the S&P 500 is +23%: 58 points behind the market.

−36%

1-year return · S&P 500 +23%

vs 200-day average
−8.5%

vs 200-day average · below trend, but not far

RSI (14)
59

RSI (14) · neutral

Below its 52-week high
−49%

Below its 52-week high

2024-08-06$2.84 – $10.87 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$3.48
1 monthS&P 500 +3.7%
+16%
1 yearS&P 500 +23%
−36%
5 yearsS&P 500 +87%
−88%
vs 50-day average$3.26
+6.8%
52-week high
$6.79
52-week low
$2.84
Annualised volatility
84%
Calendar-year price return
YearReturn
2026 (year to date)−15%
2025−39%
2024−31%
2023+28%
2022−55%
Average return by calendar month, 2021–2026
MonthYearsPositiveAverage
Jan53 of 5−3.6%
Feb52 of 5+4.9%
Mar50 of 5−25%
Apr52 of 5−9.0%
May63 of 6+7.7%
Jun63 of 6+10%
Jul64 of 6+16%
Aug62 of 6−8.2%
Sep52 of 5−5.0%
Oct51 of 5−7.9%
Nov52 of 5+2.9%
Dec51 of 5−0.10%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.